Vicarelli et al. compared RKIP levels between tumor and normal matching samples to evaluate the diagnostic potential of RKIP, ultimately finding that RKIP was significantly downregulated in the tumor samples of lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) [225]. This evidence concerns the gene PEBP1 and lung adenocarcinoma.